Burlington officials hope to encourage up to 4.4 million square feet of new development and a new series of connections between properties in and around the town’s mall. Area landlords are watching intently.
A speculative Burlington development that shifted from office to lab-ready space in 2019 was sold to MetLife Investment Management for $103 million after three life science companies leased the entire building early this year.
After failing to secure an office tenant for its Burlington Woods Drive spec development, Gutierrez Cos. decided to test the 110,000-square-foot building’s desirability among life science companies.
Burlington’s latest effort to build a new suburban Boston life science cluster is getting traction among developers and spurring new activity in office parks set to be repositioned with biotech at the forefront.
EMD Millipore Corp. has acquired its 4-year-old Burlington research campus from the original developer for $200 million.
Upgrading office and industrial buildings to lab-ready space is paying off for a growing field of developers hoping to snare the next hot biotech startup transitioning from early-stage research to commercialization.
Life science researchers are gathering in Burlington today to hear about the latest advances in areas such as genome editing, big data and STEM education.
Burlington-based Gutierrez Co. has completed lease transactions totaling more than 26,000 square feet at 200 Summit Drive, part of its three-building office complex off Middlesex Turnpike.
